NLM Gateway
A service of the U.S. National Institutes of Health
Your Entrance to
Resources from the
National Library of Medicine
    Home      Term Finder      Limits/Settings      Search Details      History      My Locker        About      Help      FAQ    
Skip Navigation Side Barintended for web crawlers only

CD8 subsets in HIV infected women in relation to disease and IDU Status: cross-sectional evaluation of the HIV epidemiological research study (HERS).

Kouitab N, Cole B, Mayer K, Flanigan T, Margolick J, Poisson M; Conference on Retroviruses and Opportunistic Infections.

Program Abstr 3rd Conf Retrovir Oppor Infect Conf Retrovir Oppor Infect 3rd 1996 Wash D C. 1996 Jan 28-Feb 1; 3rd: 136.

Providence, RI.: For the HERS Group.

Elevated levels of CD8(+)/CD38(+) in HIV-1 infected men, stratified according to CD4 absolute counts, add prognostic value in predicting disease progression. We have evaluated CD8 subsets in a cohort of women to further understand the relationship of these subsets with and disease status. In addition, we examined the effect of intravenous drug use (IDU) on this relationship. Blood was analysed by flow cytometry and dual color analysis. The panel used included monoclonal antibodies against CD3(+)/CD4(+), CD3(+) /CD8(+), CD8(+)/CD38(+), CD8(+)/HLA-DR(+), CD8(+)/CD28(+), CD57(+)/CD8(+), and CD3(+)/CD16(+) (+) CD56(+). The patients were stratified according to absolute CD4 count as follows: greater than 500 (n=82); 351-500 (48); 201-350 (58), and less than or equal to 200 (40), as well as a matched seronegative group with absolute CD4 count of greater than 500 (92). Relationships between absolute CD4 count and each of the CD8 subsets were assessed statistically by analysis of variance (ANOVA), and multiple linear regression analysis. R-squared values were used to determine the strength of each relationship. The effect of IDU was evaluated using two-way ANOVA. Results: The following CD8(+) subsets: CD3(+) , CD38(+), HLA-DR(+) and CD57(+), each were independently inversely proportional to CD4 counts (P less than 0.001 in all cases). Two-way scatterplots corroborated these negative associations. No significant differences were found in these relationships comparing IDU with non-IDU. With the exception of CD57(+)/CD8(+), the HIV-negative women had significantly lower levels of each CD8 subset as compared to the HIV-positive women with greater than 500 absolute CW4 count (P less than 0.001 in all cases). In conclusion, this confirms longitudinal observations seen in men, that the CD8(+)/CD38(+) subset correlates with disease stage. Further, IDU did not appear to affect the distribution of subsets.

Publication Types:
  • Meeting Abstracts
Keywords:
  • ADP-ribosyl Cyclase
  • AIDS Vaccines
  • Acquired Immunodeficiency Syndrome
  • Antigens, CD
  • Antigens, CD4
  • Antigens, CD57
  • Antigens, CD8
  • CD4 Lymphocyte Count
  • Cell Adhesion Molecules
  • Epidemiologic Studies
  • Female
  • HIV Infections
  • HIV Seropositivity
  • HIV-1
  • Humans
  • Male
  • Research
  • Substance Abuse, Intravenous
  • immunology
Other ID:
  • 96920447
UI: 102216498

From Meeting Abstracts




Contact Us
U.S. National Library of Medicine |  National Institutes of Health |  Health & Human Services
Privacy |  Copyright |  Accessibility |  Freedom of Information Act |  USA.gov